Operating income before deduction of amortization: Genetic Technologies (GENE)
Genetic Technologies minimizes risks by developing diagnostics for predisposition to diabetes and oncology. The consolidated EBITDA demonstrates operational resilience, where the level captures the current state. This is supported by a streamlined international system for shipping biomaterials. Fundamental growth is constrained by strict FDA and CLIA oversight, as well as the existence of exclusive patents for predictive research.
Genetic Technologies Limited (GENE) - metric breakdowns and financial figures
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Debt to Capital Ratio Genetic Technologies|GENE - Long-Term Debt to Capital|Current Liabilities to Capital Genetic Technologies Ltd|GENE - Company Debts|Debt to Book Value Ratio Genetic Technologies|GENE - Company Long-Term Debts|Short-Term Debt Genetic Technologies|Intermediate Liquidity Ratio gtglabs.com
- company profitability and valuation multiples indicators:
GENE - Net Profit|Company Profit Forecast Genetic Technologies|GENE - P/E Multiple|Projected Price to Earnings Genetic Technologies Ltd|GENE - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Genetic Technologies|GENE - Operating profit before deduction of amortization|Earnings per share for the last four quarters Genetic Technologies|GENE - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months gtglabs.com|GENE - Earnings growth in current year|Expected earnings per share growth for next year Genetic Technologies
Analysis of all company metrics:Genetic Technologies - GENE
To identify stability drivers, an investor must analyze the operating cash flow before depreciation and interest, which reflects the business's actual ability to generate cash regardless of accounting adjustments. The consolidated EBITDA trend confirms the financial resilience of Genetic Technologies, converting its flawless reputation in precision genomics and physician trust into concrete cash equivalents.
Who Genetic Technologies competes with
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit EBITDA SHC|quidel.com (QDEL) - Operating profit before depreciation charges|Operating profit EBITDA OPK (OPKO Health)|CareDx Corp (CDNA) - Profit before interest, taxes and amortization|MRVI - Profit before payment of interest, taxes and amortization|FLGT (Fulgent) - Operating profit before amortization|LAB: Operating profit EBITDA|Profit before interest, taxes and amortization cytekbio.com (CTKB)|Operating profit before deduction of amortization OSUR|XGN (Exagen Diagnostics) - Company profit before taxes, interest and amortization|Operating profit EBITDA MDXH|Operating income before deduction of amortization Lucid Diagnostics, Inc|Operating profit EBITDA PRE (Prenetics)|IMDX - Operating profit before deduction of amortization|TRIB: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization PRPH (ProPhase Labs Inc)|AIMD (Ainos Corp) - Operating profit before deduction of amortization|CODX: Company profit before taxes, interest and amortization|HSCS (Heart Test Laboratories) - Operating profit EBITDA|Profit before interest, taxes and amortization biomerica.com BMRA|Operating profit EBITDA CDIO|Operating profit before deduction of amortization Onconetix Inc ONCO|Operating profit EBITDA VRAX (Virax Biolabs Group Ltd)|Income before deduction of interest, taxes and amortization BJDX|AWH - Profit before payment of interest, taxes and amortization|AXDX (acceleratediagnostics.com) - Operating profit before amortization|Centogene N.V. (CNTG) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Enzo Biochem (ENZ)|Profit before payment of interest, taxes and amortization Fresh2 Group Ltd|Profit before payment of interest, taxes and amortization ME|Profit before payment of interest, taxes and amortization Psychemedics (PMD)
